Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Operating Expenses | 2,493 | 1,699 | 1,768 | 639 | 787 |
| Operating Income | -2,493 | -1,699 | -1,768 | -639 | -787 |
| Other Income | -2 | -12 | -4 | -14 | 9 |
| Pre-tax Income | -2,495 | -1,712 | -1,772 | -653 | -777 |
| Net Income Continuous | -2,495 | -1,712 | -1,772 | -653 | -777 |
| Net Income | $-2,495 | $-1,712 | $-1,772 | $-653 | $-777 |
| EPS Basic Total Ops | -0.14 | -0.10 | -0.11 | -0.10 | -0.12 |
| EPS Basic Continuous Ops | -0.14 | -0.10 | -0.11 | -0.10 | -0.12 |
| EPS Diluted Total Ops | -0.14 | -0.10 | -0.11 | -0.10 | -0.12 |
| EPS Diluted Continuous Ops | -0.14 | -0.10 | -0.11 | -0.10 | -0.12 |
| EBITDA(a) | $-2,492 | $-1,698 | $-1,766 | $-637 | $-785 |